All tagged FDA

Ketamine as an Effective Therapy for Treatment-resistant Depression

Major Depressive Disorder (MDD), colloquially known as depression, has plagued millions of people over the course of time, and research suggests that between 30-35% of depression cases meet the criteria to be deemed treatment-resistant depression (TRD). Despite the relatively low figure representing treatment resistance, a lot of the population experiencing depression maintains a low response rate to treatment in general. The established difficulty in treating so many cases of depression has created room for masses of research to be done regarding effective second-line remedies, and recently, the FDA has allowed depression treatment and research with drugs such as ketamine. 

Ketamine as an Effective Therapy for Treatment-resistant Depression

Major Depressive Disorder (MDD), colloquially known as depression, has plagued millions of people over the course of time, and research suggests that between 30-35% of depression cases meet the criteria to be deemed treatment-resistant depression (TRD). Despite the relatively low figure representing treatment resistance, a lot of the population experiencing depression maintains a low response rate to treatment in general. The established difficulty in treating so many cases of depression has created room for masses of research to be done regarding effective second-line remedies, and recently, the FDA has allowed depression treatment and research with drugs such as ketamine.